Company intelligence / Profile preview

Health Guard Biomed

Suzhou, Jiangsu, Chinahealthguard-biomed.com ↗

Ownership: Private
Development stage: Commercial

Overview

Health Guard Biomed is developing high-end ophthalmic implantable medical devices using advanced nano-materials and micro/nano-scale processing. Their pipeline includes innovative solutions for major eye diseases such as glaucoma, cataracts, and retinal disorders. The company is at the Series A funding stage with ongoing R&D but no reported commercialized products yet. No published clinical results are available.

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Health Guard Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Health Guard Biomed.

Explore the full profile